GENPREX (GNPX)
(Delayed Data from NSDQ)
$1.41 USD
-0.06 (-4.08%)
Updated Aug 6, 2024 03:16 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Income Statements
Fiscal Year end for GENPREX falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 31 | 24 | 20 | 18 | 11 |
Income After Depreciation & Amortization | -31 | -24 | -20 | -18 | -11 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -31 | -24 | -20 | -18 | -11 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -31 | -24 | -20 | -18 | -11 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -31 | -24 | -20 | -18 | -11 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -31 | -24 | -20 | -18 | -11 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -31 | -24 | -20 | -18 | -11 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1.37 | 1.20 | 1.18 | 0.89 | 0.40 |
Diluted EPS Before Non-Recurring Items | -22.56 | -20.00 | -16.80 | -20.40 | -26.80 |
Diluted Net EPS (GAAP) | -22.56 | -20.00 | -16.80 | -20.40 | -26.40 |
Fiscal Year end for GENPREX falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 5.99 | 5.98 | 7.79 | 8.03 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -5.99 | -5.98 | -7.79 | -8.03 |
Non-Operating Income | NA | 0.03 | 0.04 | 0.04 | 0.06 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -5.97 | -5.93 | -7.75 | -7.98 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -5.97 | -5.93 | -7.75 | -7.98 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -5.97 | -5.93 | -7.75 | -7.98 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 1.62 | NA | 1.45 | 1.30 |
Diluted EPS Before Non-Recurring Items | NA | -3.69 | NA | -5.20 | -6.00 |
Diluted Net EPS (GAAP) | NA | -3.69 | -3.76 | -5.20 | -6.00 |